Exciting news for the medical community! A groundbreaking AI-driven blood test, unveiled this week by researchers in Germany, promises to detect Parkinson’s disease up to seven years before clinical symptoms appear. This innovative diagnostic tool leverages advanced machine learning to analyze subtle biomarkers, enabling earlier intervention and potentially transforming patient outcomes. Healthcare professionals: How do you see this technology impacting neurology practices and patient care pathways?